Here are 4 forces that drove a tough week for stocks
It was a tough week for stocks as investors navigated everything from rising tensions in the Middle East to key…
investment strategy
The biotechnology recovery is not a farce. These 3 stocks could lead the next bullish leg
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of large-cap technology companies.…
Cramer Says This Stock Is Significantly Undervalued And Sees 35% Upside
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
Jim Cramer Says These Are the 5 Stocks to Buy During This Market Rotation
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…
Jim Cramer Says This Former Covid Market Favorite May Finally Be Invested Again
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
AstraZeneca CEO says AI is changing drug development and helping increase chances of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
The group led by JPMorgan Chase controls credit
The JPMorgan Chase & Co. building before the groundbreaking ceremony, at the company's new headquarters at 270 Park Avenue, in…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The liquidation of Cardinal Health was an overreaction. we would be buyers
We've taken a closer look at Cardinal Health's quarterly results and Thursday's post-settlement conference call. Our conclusion: The 4.9% drop…